Those with a rare disease are often out of luck because medicines for their disease usually cost more than their quality-adjusted life years are deemed worth.In a Commonwealth Fund/Harvard/Harris 2000 survey of physicians in the United States, Canada, New Zealand, Australia, and the United Kingdom, physicians in all countries except the United States reported major shortages of resources important